From: Medicaid prescription limits: policy trends and comparative impact on utilization
Outcome | Impact of cap implementation (% change) | 95 % Confidence interval | ||
---|---|---|---|---|
OVERALL CAP IMPLEMENTATION | ||||
Essential medications | ||||
Prescriptions | Change in level | −0.28 | −0.75 | 0.19 |
Change in slope | −0.13** | −0.21 | −0.05 | |
Expenditures | Change in level | −0.28 | −1.52 | 0.97 |
Change in slope | −0.17 | −0.66 | 0.32 | |
Preventive essential medications | ||||
Prescriptions | Change in level | −0.47 | −1.05 | 0.1 |
Change in slope | −0.28** | −0.46 | −0.11 | |
Expenditures | Change in level | −0.44 | −1.35 | 0.46 |
Change in slope | −0.30** | −0.43 | −0.17 | |
Symptomatic essential medications | ||||
Prescriptions | Change in level | 0.19** | 0.07 | 0.31 |
Change in slope | 0.14 | −0.05 | 0.34 | |
Expenditures | Change in level | 0.15 | −0.31 | 0.61 |
Change in slope | 0.11 | −0.49 | 0.71 | |
BRAND CAP IMPLEMENTATION | ||||
All brand medications | ||||
Prescriptions | Change in level | −2.29* | −4.16 | −0.42 |
Change in slope | −0.02 | −0.23 | 0.18 | |
Expenditures | Change in level | −1.26* | −2.36 | −0.16 |
Change in slope | 0.08 | −0.19 | 0.35 | |
Brand medications in classes with generic replacements a | ||||
Prescriptions | Change in level | −0.74** | −1.23 | −0.25 |
Change in slope | 0.02 | −0.22 | 0.26 | |
Expenditures | Change in level | −1.27** | −2.01 | −0.53 |
Change in slope | 0.05 | −0.29 | 0.40 | |
Generic medication in classes with generic replacements a | ||||
Prescriptions | Change in level | 0.79** | 0.20 | 1.38 |
Change in slope | −0.08 | −0.19 | 0.03 | |
Expenditures | Change in level | 0.60 | −0.12 | 1.31 |
Change in slope | −0.03 | −0.13 | 0.08 |